NGM Biopharmaceuticals
Why Robinhood?
You can watch NGM and buy or sell other stocks, ETFs, and their options commission-free!About NGM
NGM Biopharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel biologic drug candidates. Its programs include NGM707 and pembrolizumab for treating metastatic solid tumors, Aldafermin for primary sclerosing cholangitis, and NGM120 for hyperemesis gravidarum.
NGM Key Statistics
Stock Snapshot
The current NGM Biopharmaceuticals(NGM) stock price is $1.54, with a market capitalization of 128.53M. The stock trades at a price-to-earnings (P/E) ratio of -0.89.
On 2026-05-16, NGM Biopharmaceuticals(NGM) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for NGM Biopharmaceuticals(NGM) stock has reached 0, versus its average volume of 536.23K.
The stock's 52-week range extends from a low of $0.60 to a high of $4.69.
The stock's 52-week range extends from a low of $0.60 to a high of $4.69.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.